Effect of SMP-300, a New Na^+/H^+ Exchange Inhibitor, on Myocardial Ischemia and Experimental Angina Models in Rats
スポンサーリンク
概要
- 論文の詳細を見る
We evaluated the effects of SMP−300(N−(aminoiminomethyl)−11−chloro−5, 6, 7, 8−tetrahydro−8−oxo−4H−pyrrolo[3, 2, 1−kl][1]benzazocine−2−carboxamide monomethanesulfonate monohydrate), a newly synthesized compound, on Na+/H+ exchange activity in rat cardiomyocytes and on other ion transporters, channels and receptors.We also investigated the protective effects of SMP−300 in isolated ischemic rat hearts and rat isoproterenol− or vasopressin−induced experimental angina models.SMP−300 concentration−dependently inhibited recovery from acidosis in rat myocytes, and its IC50 for Na+/H+ exchange was 6 nM.In comparison, its IC50s for Na+/Ca2+ exchange and for the Na+ channel were >1000 nM, and those for other channels or receptors tested were >10, 000 nM.In rat isolated perfused hearts, SMP−300(10-8−10-7M), administered only at preischemia and not during reperfusion, significantly improved the postischemic recovery of cardiac function.SMP−300(0.03−0.3 mg/kg, i.v.)or 5−(N−ethyl−N−isopropyl)−amiloride(1 mg/kg, i.v.)prevented the isoproterenol−induced ST−segment depression in the ECG of anesthetized rats, in a dose−dependent manner.SMP−300(0.1 mg/kg, i.v.)and 5−(N−ethyl−N−isopropyl)−amiloride(1 mg/kg, i.v.)also inhibited the vasopressin−induced ST−segment depression in the ECG of anesthetized rats.This is the first report presenting the protective effect of Na+/H+ exchange inhibitors on isoproterenol− or vasopressin−induced ECG changes in rats, providing the future perspective of SMP−300, a potent Na+/H+ exchange inhibitor, as an anti−anginal drug.
- 社団法人 日本薬理学会の論文
- 2000-10-01
著者
-
Ohashi Naohito
Research Center Sumitomo Pharmaceuticals Co. Ltd
-
Matsui Kazuki
Research Center Sumitomo Pharmaceuticals Co. Ltd
-
Yamamoto S
Saga Medical School Saga Jpn
-
YAMAMOTO Setsuko
Research Center, Sumitomo Pharmaceuticals Co., Ltd
-
SASABE Masao
Research Center, Sumitomo Pharmaceuticals Co., Ltd
-
KITANO Masahumi
Research Center, Sumitomo Pharmaceuticals Co., Ltd
-
Sasabe Masao
Research Center Sumitomo Pharmaceuticals Co. Ltd
関連論文
- Structure-Activity Relationships of 3-Methyl and 3,3-Dimethyl Analogs of 2-(2,4-Difluorophenyl)-3-(ω-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-ipropanols
- Asymmetric Synthesis of SM-9164, a Biologically Active Enantiomer of Antifungal Agent SM-8668
- Sterospecific Actolysis of threo- and erythro-2-Aryl-2-[1-methylthio)ethl]oxiranes
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
- Synthesis and Biological Activity of N-(Aminoiminomethyl)-1H-indole Carboxamide Derivatives as Na^+/H^+ Exchanger Inhibitors
- Optical Resolution of dl-threo-2-(2,4-Difluorophenyl)-2-[1-(methylthio)ethyl] oxirane: Its Application to the Synthesis of SM-9164, a biologically Active Anantiomer of Antifungal Agent SM-8668
- Protective Effect of SM-19712, a Novel and Potent Endothelin Converting Enzyme Inhibitor, on Ischemic Acute Renal Failure in Rats
- Design, Synthesis, and Structure-Activity Relationships of 3,4-Dihydropyridopyrimidin-2(1H)-one Derivatives as a Novel Class of Sodium/Calcium Exchanger Inhibitor
- Relationship between the Neuroprotective Effect of Na^+/H^+ Exchanger Inhibitor SM-20220 and the Timing of Its Administration in a Transient Middle Cerebral Artery Occlusion Model of Rats
- Effect of SMP-300, a New Na^+/H^+ Exchange Inhibitor, on Myocardial Ischemia and Experimental Angina Models in Rats
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na^+ Excretion Activity